Press release

DSM reports very strong start to 2010 in an improved business environment

Heerlen, NL, 28 Apr 2010 08:15 CEST

  • Q1 operating profit from continuing operations €196 million (versus €44 million in Q1 2009 and €149 million in Q4 2009)
  • Organic sales growth from continuing operations +25% compared to Q1 2009
  • Life Sciences continues to deliver robust results due to Nutrition
  • Materials Sciences demonstrates further strong recovery
  • Major step in transformation with the sale of DSM Agro and DSM Melamine
  • Robust cash performance continues with €137 million cash from operating activities
  • 2010 is expected to be a good year for DSM

Commenting on the results, Feike Sijbesma, Chairman of the DSM Managing Board, said: “I am pleased to report that DSM has delivered a very strong start to 2010. Operating profit from our core businesses is not only up very strongly compared to Q1 2009, it has also returned to the level achieved in Q1 2008. This reflects the outstanding performance of our Nutrition business, a continuing strong recovery in our Materials Sciences businesses and cost savings initiatives taken last year which already deliver €200 million on an annualized basis.

Throughout the downturn, DSM has stayed the course - fully committed to our customers, innovation and sustainability. The announced sale of DSM Agro and DSM Melamine marks another important step in our transformation towards a Life Sciences and Materials Sciences company. Whilst uncertainties remain in the medium term economic outlook, the strong Q1 result and continued positive business conditions give us confidence that 2010 will be a good year for DSM.”

Key figures

in € million Q1 2010 Q1 2009 +/-
Continuing operations      
Net sales 2,088 1,690 24%
Operating profit before depreciation & amortization (EBITDA) 304 142 114%
Operating profit (EBIT) 196 44 345%
Nutrition 138 141 -2%
Pharma 1 11 -91%
Performance Materials 43 -17  
Polymer Intermediates 43 -30  
Base Chemicals and Materials 18 -15  
Other activities -47 -46  
Discontinued operations:      
Net sales 142 147  
Operating profit before depreciation & amortization (EBITDA) 31 25  
Operating profit (EBIT) 22 13  
Total DSM:      
Net sales 2,230 1,837 21%
Operating profit (EBIT) 218 57 282%
Net profit before exceptional items 144 25 476%
Net result from exceptional items -14 -12  
Net profit 130 13  
Net earnings per ordinary share in €:      
before exceptional items, continuing operations 0.77 0.07  
including exceptional items, total DSM 0.78 0.06  

You can find the press release in full, including financial statements, below.

For more information

Lieke de Jong-Tops

Senior Communications Manager
+31 45 578 2420
media.contacts@dsm.com

Dave Huizing

Vice President Investor Relations
+31 45 578 2864
investor.relations@dsm.com

Media Relations

+31 45 578 2420

Investor Relations

+31 45 578 2864

This site uses cookies to store information on your computer.

Learn more